Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04547049 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Sep 1, 2025 to Apr 1, 2026v7 Show 8 more changesShow less
    • Primary endpoint revised
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: 176 to 232
    • Study completion date: Dec 31, 2025 to Apr 1, 2026
    • Eligibility criteria revised
    • Secondary endpoints revised (6)
    • Study description revised
    • Site details revised at 8 of 8 sites
  2. Enrollment target: 160 to 176
    • Secondary endpoints: details revised at 1 of 6 entries
    • Study description revised
    • Study sites revised (8)
    v6
  3. Eligibility criteria shortened, about 21 words
    • Study sites revised (8)
    • Study description shortened, about 1 word
    v5
  4. Re-verified, no change to tracked fieldsv4
  5. Study sites: 7 to 8v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An open, multi-center, randomized trial comparing haploidentical HSCTs from young non-first-degree and older first-degree donors in hematological malignancies
Trial Details
NCT Number NCT04547049
Lead Sponsor First Affiliated Hospital of Zhejiang University
Conditions
(from sponsor)		 Leukemia, MDS
Related terms Leukemia
Enrollment 232 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov